Data gathered: November 27
AI Stock Analysis - Adial Pharmaceuticals (ADIL)
Analysis generated April 23, 2024. Powered by Chat GPT.
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addiction and related disorders. The flagship product candidate of Adial is AD04, a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder (AUD). The uniqueness of this approach lies in the personalized treatment paradigm based on genetic markers. The company's mission is to provide effective treatment options for patients with addiction problems where there is a significant unmet medical need.
Stock Alerts - Adial Pharmaceuticals (ADIL)
 |
Adial Pharmaceuticals | November 18 Price is down by -5.2% in the last 24h. |
|
Adial Pharmaceuticals | November 15 Price is down by -5.3% in the last 24h. |
|
Adial Pharmaceuticals | November 14 Price is up by 10% in the last 24h. |
|
Adial Pharmaceuticals | November 8 Price is down by -5.6% in the last 24h. |
Alternative Data for Adial Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Employee Rating | 20 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 2 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 3 | Sign up | Sign up | Sign up |
| Facebook Followers | 453 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 7,396 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,201 | Sign up | Sign up | Sign up |
| Twitter Mentions | 13 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 136 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 13 | Sign up | Sign up | Sign up |
About Adial Pharmaceuticals
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
| Price | $0.99 |
| Target Price | Sign up |
| Volume | 134,530 |
| Market Cap | $6.5M |
| Year Range | $0.95 - $2.98 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
ADIL FY2024 EPS Forecast Lifted by Litchfield Hills ResearchNovember 26 - ETF Daily News |
 |
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should KnowNovember 25 - Yahoo |
 |
Rodman & Renshaw Initiates Coverage on Adial Pharmaceuticals (NASDAQ:ADIL)November 17 - ETF Daily News |
|
Adial Pharmaceuticals (NASDAQ:ADIL) Upgraded at RODMAN&RENSHAWNovember 16 - ETF Daily News |
 |
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use DisorderNovember 13 - Yahoo |
 |
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use DisorderNovember 13 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 1.2M | -1.2M | -2.2M | -2.2M | 0.000 |
| Q2 '24 | 82,000 | 1.3M | -1.3M | -2.5M | -2.3M | -0.590 |
| Q1 '24 | 32,000 | 5.9M | -5.9M | -6.5M | -1.8M | -0.620 |
| Q4 '23 | 7.5M | 1.5M | -1.5M | -1.9M | -1.8M | -1.350 |
| Q3 '23 | 0 | 1.2M | -1.2M | -1.4M | -1.4M | -1.180 |
Insider Transactions View All
| Schuyler Kevin filed to buy 700 shares at $2.7. October 3 '23 |
| Newman James W. Jr. filed to buy 50,221 shares at $2.7. January 3 '22 |
| Newman James W. Jr. filed to buy 34,644 shares at $2.7. January 3 '22 |
Similar companies
Read more about Adial Pharmaceuticals (ADIL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Adial Pharmaceuticals?
The Market Cap of Adial Pharmaceuticals is $6.5M.
What is the current stock price of Adial Pharmaceuticals?
Currently, the price of one share of Adial Pharmaceuticals stock is $0.99.
How can I analyze the ADIL stock price chart for investment decisions?
The ADIL stock price chart above provides a comprehensive visual representation of Adial Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Adial Pharmaceuticals shares. Our platform offers an up-to-date ADIL stock price chart, along with technical data analysis and alternative data insights.
Does ADIL offer dividends to its shareholders?
As of our latest update, Adial Pharmaceuticals (ADIL) does not offer dividends to its shareholders. Investors interested in Adial Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Adial Pharmaceuticals?
Some of the similar stocks of Adial Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.